Frontlight ResearchEarly access
Neuroendocrine tumours trials in China
15 of 62 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationLiver Transplantation Versus Conventional Medical Therapy for Low-Grade GEP-NET With Liver Metastases
- Where
- Tianjin
- Age
- 18 years to 70 years
- People
- 100
- Run by
- Chiyi Chen
See details and how to joinNCT07913113 - No phaseNot yet taking people in ChinaImmunotherapy in Neuroendocrine Carcinoma of the Cervix
- Where
- Beijing
- Age
- 18 years to 100 years
- People
- 150
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07911423 - No phaseTaking peopleIncremental Value of Delayed 68Ga-DOTATATE PET/MR in the Detection of Liver Metastases
- Where
- Fuzhou
- Age
- 30 years to 74 years
- People
- 46
- Run by
- First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT07898904 - No phaseEnrolling by invitationOxaliplatin-Based Adjuvant Therapy for Gastrointestinal Neuroendocrine Carcinoma**
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 42
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07891572 - No phaseNot yet taking people in ChinaMulti-omics Study of Cervical Neuroendocrine Carcinoma
- Where
- Beijing
- Age
- 18 years to 100 years
- People
- 120
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07879339 - No phaseTaking peopleA Comparative Study of Patients Undergoing Surgery for Pituitary Neuroendocrine Tumors Detected by Different Ways
- Where
- Beijing
- Age
- 1 year to 85 years
- People
- 5,000
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT07835412 - No phaseNot yet taking people in ChinaReal-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors
- Where
- Xiamen
- Age
- 18 years and over
- People
- 60
- Run by
- Yefeng
See details and how to joinNCT07780539 - No phaseTaking peoplePlasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors
- Where
- Chengdu, Shanghai
- Age
- 18 years and over
- People
- 1,000
- Run by
- Fudan University
See details and how to joinNCT05847855 - No phaseNot yet taking people in ChinaManagement of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
- Where
- Wuhan
- Age
- 18 years and over
- People
- 500
- Run by
- Huazhong University of Science and Technology
See details and how to joinNCT07463872 - No phaseTaking peopleAI-Powered Precision Decision-Making for Pancreatic Diseases
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 2,000
- Run by
- Changhai Hospital
See details and how to joinNCT07439757 - No phaseTaking people18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 20
- Run by
- Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT06937112 - No phaseEnrolling by invitationEvaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 20
- Run by
- Ding Ma
See details and how to joinNCT06810895 - No phaseTaking peopleNeuroendocrine Transformation in RB1/TP53 Inactivated NSCLC
- Where
- Shanghai
- Age
- 18 years and over
- People
- 50
- Run by
- Fudan University
See details and how to joinNCT06369181 - No phaseNot yet taking people in ChinaA Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors
- Where
- Jinan
- Age
- 18 years and over
- People
- 500
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT06300216 - No phaseTaking peoplePredictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors
- Where
- Guangzhou
- Age
- 18 years to 70 years
- People
- 300
- Run by
- Sun Yat-sen University
See details and how to joinNCT06015802